Creative Medical Technology Holdings, Inc. Finite-Lived Intangible Asset, Expected Amortization, Year One
Creative Medical Technology Holdings, Inc. (CELZ) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $84.78 thousand as of 2025-12-31, per its 10-K filed 2026-03-20.
Financial Statements › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2026-03-20
- 2025-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $84.78K.
- 2024-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $121.95K.
- 2023-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $102.08K.
- 2019-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $67.21K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2025-12-31 | $84.78K 10-K · filed 2026-03-20 |
| 2024-12-31 | $121.95K 10-K · filed 2025-03-14 |
| 2023-12-31 | $102.08K 10-K · filed 2024-03-22 |
| 2019-12-31 | $67.21K 10-K · filed 2020-04-06 |
| 2018-12-31 | $21.14K 10-K · filed 2019-04-01 |
| 2017-12-31 | $21.14K 10-K · filed 2018-03-29 |
| 2016-12-31 | $11.18K 10-K · filed 2017-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |